Source: FDA, National Drug Code (US) Revision Year: 2019
Radiogardase (prussian blue insoluble) is a decorporation agent for oral use. Radiogardase capsules contain insoluble ferric hexacyanoferrate(II), with an empirical formula of Fe4[Fe(CN)6]3 and a molecular weight of 859.3 Daltons. It is supplied as 0.5 gram of blue powder in gelatin capsules with 0–38 mg of microcrystalline cellulose. The dark blue capsule is imprinted with the light blue inscription: 
The crystal structure of prussian blue insoluble is a cubic lattice with the FeII and FeIII atoms occupying the corners of the cube and the cyanide groups positioned on the sides.
| Dosage Forms and Strengths |
|---|
|
Capsules: 0.5 grams – dark blue capsule is imprinted with the light blue inscription: |
| How Supplied |
|---|
|
Radiogardase is supplied as gelatin capsules containing 0.5 grams of prussian blue insoluble for oral administration. The dark blue capsule is imprinted with the light blue inscription:
Manufactured by: Haupt Pharma, Berlin GmbH Distribution by: HEYL Chemisch-pharmazeutische, Fabrik GmbH & Co. KG, Berlin |
| Drug | Countries | |
|---|---|---|
| RADIOGARDASE | France, Japan, United States |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
